Financial statements Biomocna
Balance sheet data of BIOMOCNA
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 783 629,53 | 904 648,13 | 1 024 073,82 | 1 671 789,96 | 3 789 659,30 | 5 235 786,23 |
A. Fixed assets | 83 770,77 | 257 490,79 | 213 471,25 | 203 687,76 | 364 071,21 | 471 691,88 |
B. Current assets | 699 858,76 | 647 157,34 | 810 602,57 | 1 468 102,20 | 3 425 588,09 | 4 764 094,35 |
C. Share capital contributions (basic funds) | - | - | - | - | - | - |
D. Own shares (stocks) | - | - | - | - | - | - |
Total liabilities | 783 629,53 | 904 648,13 | 1 024 073,82 | 1 671 789,96 | 3 789 536,30 | 5 235 786,23 |
A. Equity | 405 375,24 | 450 777,21 | 655 986,30 | 1 406 994,79 | 3 478 268,20 | 4 740 172,45 |
B. Liabilities and provisions for liabilities | 378 254,29 | 453 870,92 | 368 087,52 | 264 795,17 | 311 268,10 | 495 613,78 |
I. Long-term liabilities | - | - | - | - | - | - |
II. Short-term liabilities | - | - | - | - | 311 268,10 | 495 613,78 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.